You are here:

Biotech & Biomedical/For the deailed molecular level

Advertisement


Question
Hi Paul,
For that hydralazine is under acetylation,the slow acetylator people will have more chance to get lupus-like syndrome.
However,is there any molecular interpretation given to the metabolites of hydralazine(or hydralazine itself) and the response(lupus -like syndrome)?
thanks.

Answer
Hello again, Sinn,

The mechanism of lupus from hydralazine is still unclear - most likely an autoimmune reaction - this is thought to be from the reaction of the parent compound (hydralazine itself) or one of its oxidation products with cellular components. Increase in slow acetylators is likely due, therefore, to more unchanged drug being present or more of the drug being availble for processing down the oxidation pathway.

There are a number of potential routes of drug-induced autoimmune reactions  - see:

Environmental Health Perspectives volume 107 supplement 5 pages 737-742 (1999).

Hope this helps.

Best wishes,

Paul  

Biotech & Biomedical

All Answers


Answers by Expert:


Ask Experts

Volunteer


Dr.Paul Skett

Expertise

drug metabolism or biotransformation from basic to advanced, hepatocytes from basic to advanced, drug toxicity and side effects, alcohol clearance and levels

Experience

32 years research experience in above areas, 30 years educational experience in University. Retained expert for numerous legal firms dealing with matters of drugs (legal and illegal)and alcohol.

Education/Credentials
B.Sc(Hons) Biochemistry, University of Liverpool, UK
fil.dr. (Medical Chemistry) Karolinska Institute, Stockholm, Sweden

Fellow of the British Pharmacological Society

Fellow of the Higher Education Academy

©2012 About.com, a part of The New York Times Company. All rights reserved.